Clinical Trials Browser

Phase 1 × Breast Neoplasms × Population Groups × Clear all

NCT06770296 2025-01-13

The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study

Phase 1 Recruiting

Breast Neoplasms